Martin Van Trieste, SVP of Quality at AMGEN, Ann Daly, SAFC Director of Sales and Tom Beil, SAFC VP of Quality and Regulatory Affairs take a moment to smile for the cameras at the build site in New Orleans, LA.
This entry was posted on Wednesday, February 29th, 2012 at 10:25 pm and is filed under .
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.
22 May 2013
Mythbusters: Biotech Venture Capital
This from the LifeSci VC blog this morning. A post on the myths that persist in the popular conscience about biotech venture capital. Since they are characterized as "myths", then it follows...
20 May 2013
Pharma R&D Spending vs Other Industries
Here's an interesting post from the In the Pipeline blog that comments on the amount of R&D spending that is seen in Big Pharma versus what occurs in all sorts of other industries. It turns out th...
17 May 2013
Innovation as Illustrated by Beer
It's not often that you get a blog post that talks to innovation and uses references to both Homer Simpson and beer to drive home its point. Today's award goes to the Innovate on Purpose blog for -- w...
16 May 2013
Global Biosimilar Market Report 2013
Visiongain published a new report on the global biosimilar market in 2013 and says the market size will reach $2.45 B, or approximately 20% higher than last year. Biosimilars now account for about 2% ...